Clinical Trial Update: No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays

View source ↗

Summary

A recruiting clinical trial evaluating a no-biopsy approach to diagnosing Celiac disease using cut-off points for IgA anti-tissue transglutaminase assays.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Celiac Disease | Status: RECRUITING